These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 28734802)

  • 1. Co-transplantation of mesenchymal and neural stem cells and overexpressing stromal-derived factor-1 for treating spinal cord injury.
    Stewart AN; Kendziorski G; Deak ZM; Brown DJ; Fini MN; Copely KL; Rossignol J; Dunbar GL
    Brain Res; 2017 Oct; 1672():91-105. PubMed ID: 28734802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDF-1 overexpression by mesenchymal stem cells enhances GAP-43-positive axonal growth following spinal cord injury.
    Stewart AN; Matyas JJ; Welchko RM; Goldsmith AD; Zeiler SE; Hochgeschwender U; Lu M; Nan Z; Rossignol J; Dunbar GL
    Restor Neurol Neurosci; 2017; 35(4):395-411. PubMed ID: 28598857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor mesenchymal stem cell-derived neural-like cells transdifferentiate into myelin-forming cells and promote axon regeneration in rat spinal cord transection.
    Qiu XC; Jin H; Zhang RY; Ding Y; Zeng X; Lai BQ; Ling EA; Wu JL; Zeng YS
    Stem Cell Res Ther; 2015 May; 6(1):105. PubMed ID: 26012641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.
    Shi W; Huang CJ; Xu XD; Jin GH; Huang RQ; Huang JF; Chen YN; Ju SQ; Wang Y; Shi YW; Qin JB; Zhang YQ; Liu QQ; Wang XB; Zhang XH; Chen J
    Acta Biomater; 2016 Nov; 45():247-261. PubMed ID: 27592818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant use of mesenchymal stem cells and neural stem cells for treatment of spinal cord injury: A combo cell therapy approach.
    Hosseini SM; Sani M; Haider KH; Dorvash M; Ziaee SM; Karimi A; Namavar MR
    Neurosci Lett; 2018 Mar; 668():138-146. PubMed ID: 29317311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats.
    Roh DH; Seo MS; Choi HS; Park SB; Han HJ; Beitz AJ; Kang KS; Lee JH
    Cell Transplant; 2013; 22(9):1577-90. PubMed ID: 23294734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SDF-1/CXCR4 Signaling Pathway Directs the Migration of Systemically Transplanted Bone Marrow Mesenchymal Stem Cells Towards the Lesion Site in a Rat Model of Spinal Cord Injury.
    Zhao A; Chung M; Yang Y; Pan X; Pan Y; Cai S
    Curr Stem Cell Res Ther; 2023; 18(2):216-230. PubMed ID: 35538804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroacupuncture promotes the differentiation of transplanted bone marrow mesenchymal stem cells overexpressing TrkC into neuron-like cells in transected spinal cord of rats.
    Ding Y; Yan Q; Ruan JW; Zhang YQ; Li WJ; Zeng X; Huang SF; Zhang YJ; Wu JL; Fisher D; Dong H; Zeng YS
    Cell Transplant; 2013; 22(1):65-86. PubMed ID: 23006476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
    Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats.
    Liu J; Chen J; Liu B; Yang C; Xie D; Zheng X; Xu S; Chen T; Wang L; Zhang Z; Bai X; Jin D
    J Neurol Sci; 2013 Feb; 325(1-2):127-36. PubMed ID: 23317924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of induced pluripotent stem cell-derived motor neuron progenitor cells with irradiated brain-derived neurotrophic factor over-expressing engineered mesenchymal stem cells enhanced restoration of axonal regeneration in a chronic spinal cord injury rat model.
    Kim JW; Kim J; Lee SM; Rim YA; Sung YC; Nam Y; Kim HJ; Kim H; Jung SI; Lim J; Ju JH
    Stem Cell Res Ther; 2024 Jun; 15(1):173. PubMed ID: 38886817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mash-1 modified neural stem cells transplantation promotes neural stem cells differentiation into neurons to further improve locomotor functional recovery in spinal cord injury rats.
    Deng M; Xie P; Chen Z; Zhou Y; Liu J; Ming J; Yang J
    Gene; 2021 May; 781():145528. PubMed ID: 33631250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of Mesenchymal Stem Cells for Acute Spinal Cord Injury in Rats: Comparative Study between Intralesional Injection and Scaffold Based Transplantation.
    Kim YC; Kim YH; Kim JW; Ha KY
    J Korean Med Sci; 2016 Sep; 31(9):1373-82. PubMed ID: 27510379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation.
    Karaoz E; Kabatas S; Duruksu G; Okcu A; Subasi C; Ay B; Musluman M; Civelek E
    Turk Neurosurg; 2012; 22(2):207-17. PubMed ID: 22437296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats.
    Ma J; Liu N; Yi B; Zhang X; Gao BB; Zhang Y; Xu R; Li X; Dai Y
    Neurol Res; 2015 Jan; 37(1):50-6. PubMed ID: 24919714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury.
    Kumagai G; Tsoulfas P; Toh S; McNiece I; Bramlett HM; Dietrich WD
    Exp Neurol; 2013 Oct; 248():369-80. PubMed ID: 23856436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.
    Abrams MB; Dominguez C; Pernold K; Reger R; Wiesenfeld-Hallin Z; Olson L; Prockop D
    Restor Neurol Neurosci; 2009; 27(4):307-21. PubMed ID: 19738324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord rats.
    Alexanian AR; Kwok WM; Pravdic D; Maiman DJ; Fehlings MG
    Restor Neurol Neurosci; 2010; 28(6):761-7. PubMed ID: 21209491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of mesenchymal stem cells that overexpress NT-3 produce motor improvements without axonal regeneration following complete spinal cord transections in rats.
    Stewart AN; Kendziorski G; Deak ZM; Bartosek NC; Rezmer BE; Jenrow K; Rossignol J; Dunbar GL
    Brain Res; 2018 Nov; 1699():19-33. PubMed ID: 29883625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.